openPR Logo
Press release

Clinical Trials Management System Market Top Players - Oracle; DATATRAK International, Inc.; Clario; SimpleTrials; Calyx; RealTime Software Solutions.

07-23-2025 07:58 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

Clinical Trials Management System Market

Clinical Trials Management System Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2034"

The global Clinical Trials Management System market is estimated to reach over 7.3 billion by the year 2034 , exhibiting a CAGR of 13.7% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1684

The clinical trial management systems (CTMS) market is experiencing substantial growth, primarily driven by the rising prevalence of chronic and lifestyle-related diseases, as well as the growing trend of outsourcing clinical trials to contract research organizations (CROs). According to the Alzheimer's Association (2021), Alzheimer's dementia disproportionately affects the elderly population in the United States, with prevalence rates of 5.3% among individuals aged 65-74, 13.8% among those aged 75-84, and 34.6% among those 85 and older. The increasing burden of such chronic illnesses is expected to fuel the demand for specialized clinical trials, thereby driving the adoption of CTMS solutions and supporting overall market expansion.

Furthermore, the CTMS market is benefiting from significant research and development (R&D) investments by pharmaceutical and biopharmaceutical companies. As reported by the European Federation of Pharmaceutical Industries and Associations (EFPIA) in 2022, R&D expenditures in 2020 totaled approximately EUR 39.7 billion in Europe, USD 72.4 billion in the United States, and CNY 78.5 billion in China.

These investments are instrumental in advancing clinical trial initiatives, leading to increased utilization of CTMS platforms. Additionally, technological advancements aimed at optimizing trial management and reducing associated costs continue to strengthen market growth. For instance, in September 2021, Total Clinical Trial Management (TCTM) launched the "TOTAL Diversity" initiative, underscoring the industry's ongoing efforts to improve efficiency and cost-effectiveness in clinical research operations.

List of Prominent Players in the Clinical Trials Management System Market:
• IQVIA Inc.;
• Medidata (Dassault Systèmes);
• Oracle;
• DATATRAK International, Inc.;
• Clario
• SimpleTrials;
• Calyx;
• RealTime Software Solutions, LLC;
• Laboratory Corporation of America Holdings;
• Veeva Systems; Wipro Limited;
• PHARMASEAL International Ltd

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-01

Market Dynamics
Drivers:
The clinical trial management systems (CTMS) market is expected to witness robust growth, primarily driven by the increasing implementation of decentralized clinical trials (DCTs). These trials utilize telemedicine and other digital health technologies and are often referred to as virtual, mobile, remote, or siteless trials. A key example includes Labcorp's DCT offering, which delivers a comprehensive infrastructure, advanced technology solutions, and support services designed to streamline the design and execution of decentralized trials. Additionally, the availability of advanced CTMS platforms from leading market players is further propelling adoption. For instance, Medidata's Rave CTMS offers a comprehensive automation and workflow management solution that enhances operational efficiency and monitoring of clinical trials.

Challenges:
While the market outlook remains positive, data privacy and cybersecurity concerns present notable challenges. The integration of cloud computing and big data analytics into CTMS platforms brings operational and cost benefits but also increases the risk of data breaches and compliance issues. As a result, the implementation of robust data protection frameworks and adherence to regulatory standards are essential for mitigating these risks and ensuring secure clinical trial operations.

Regional Trends:
North America, particularly the United States, remains the leading regional market for CTMS, driven by substantial investment in research and development and a strong demand for novel therapeutic solutions. According to data from ClinicalTrials.gov, as of July 2022, North America accounted for 173,066 active clinical trials, with the United States alone representing 155,448 of these. This high volume of research activity, coupled with sustained financial support for clinical innovation, is expected to continue driving CTMS market growth across the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1684

Recent Developments:
• In March 2022, THREAD and Amazon Web Services agreed to work together. AWS will help develop new THREAD platform features by providing scalable automation and integrated AI to enable quicker and more effective trials by enabling higher quality data collecting throughout the clinical study lifecycle.

Segmentation of Clinical Trials Management System Market-
By Solution Type-
• Enterprise
• Site
By Delivery Mode-
• Web & Cloud-based
• On-premise
By Component-
• Software
• Services
By End User-
• Pharmaceutical and Biotechnology Firms
• Medical Device Firms
• CROs & Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/clinical-trials-management-system-market/1684

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trials Management System Market Top Players - Oracle; DATATRAK International, Inc.; Clario; SimpleTrials; Calyx; RealTime Software Solutions. here

News-ID: 4115338 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Food Enzymes Market Know the Scope and Trends
Food Enzymes Market Know the Scope and Trends
"Food Enzymes Market" in terms of revenue was estimated to be worth $1.57 billion in 2023 and is poised to reach $2.57 billion by 2031, growing at a CAGR of 6.47% from 2024 to 2031 according to a new report by Insight Ace Analytic. Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1416 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Food Enzymes market are: • Increasing Demand for Processed Food • Increasing Demand
Eco-friendly Food Packaging Market Exclusive Trends Analysis with Forecast to 2034
Eco-friendly Food Packaging Market Exclusive Trends Analysis with Forecast to 20 …
"Eco-friendly Food Packaging Market" in terms of revenue was estimated to be worth $ 232.9 Billion in 2024 and is poised to reach $ 585.0 Billion by 2034, growing at a CAGR of 9.8% from 2025 to 2034 according to a new report by InsightAce Analytic. Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1398 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global eco-friendly food packaging market are: • Technological advancement
Corrugated Boxes Market Exclusive Report with Detailed Study Analysis
Corrugated Boxes Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Corrugated Boxes Market Size, Share & Trends Analysis Report By Material (Linerboard, Medium), Printing Ink( Water-based, UV-curable, Hot melt-based, Solvent-Based), Printing Technology (Digital, Flexography, Lithography), Type (Slotted Boxes, Telescope Boxes, Rigid Boxes, And Folder Boxes), End-Use Industry (Food & Beverages, Electronic Goods, Home & Personal Care, Chemicals, Textile, Glassware & Ceramics, Paper Products)- Market Outlook
Compound Beverage Stabilizing Additives Market Exclusive Report on the Latest Revenue and Future Scope
Compound Beverage Stabilizing Additives Market Exclusive Report on the Latest Re …
"Compound Beverage Stabilizing Additives Market" in terms of revenue is expected to grow at a CAGR of 6.8% from 2025 to 2034 according to a new report by InsightAce Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1420 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global Compound Beverage Stabilizing Additives market are: ● Growing Consumer Preferences ● Growing Consumer Awareness of Health and Wellness ● Technological Advancements The following are the primary obstacles to the Compound

All 5 Releases


More Releases for Trial

Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period. Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials
Clinical Trial Logistics
Announcing SMi's 5th annual… Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK www.smi-online.co.uk/2011logistics-london6.asp It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical